Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Donti

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Prenatal Diagnosis|December 13, 2000
MASA syndrome: ultrasonographic evidence in a male fetusG Pomili, G Venti Donti, L Alunni Carrozza, et al.
Genomics|February 1, 1990
cDNA isolation, expression analysis, and chromosomal localization of two human zinc finger genesL Lania, E Donti, A Pannuti, et al.
European Journal of Haematology|September 1, 1995
Interferon-alpha plus low-dose cytosine arabinoside in advanced phase chronic myelogenous leukaemia patientsA Ferrajoli, A M Liberati, P Caricchi, et al.
Genetic Counseling (Geneva, Switzerland)|April 28, 2010
Familial pericentric inversion of chromosome 18: intrafamilial variability of the recombinant dup(18q)P Prontera, B Buldrini, V Aiello, et al.
European Journal of Pediatrics|April 1, 1983
Clinical heterogeneity in Sanfilippo disease (mucopolysaccharidosis III) type D: presentation of two new casesG V Coppa, P L Giorgi, L Felici, et al.
European Journal of Haematology|March 1, 1994
Repeated PCR in CML during IFN-alpha therapyA M Liberati, E Donti, C Rosso, et al.
Oncogene|October 1, 1990
Mapping of chromosome 17 breakpoints in acute myeloid leukemiasL Longo, E Donti, A Mencarelli, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Evolving modalities of treatment with interferon alfa-2b for Ph1-positive chronic myelogenous leukaemiaE Morra, G Alimena, M Lazzarino, et al.
Cancer Genetics and Cytogenetics|October 1, 1996
Complex chromosome translocations of standard t(8;21) and t(15;17) arise from a two-step mechanism as evidenced by fluorescence in situ hybridization analysisG Calabrese, T Min, L Stuppia, et al.
Blood|August 1, 1988
Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administrationG Alimena, E Morra, M Lazzarino, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Prenatal Diagnosis|December 13, 2000
MASA syndrome: ultrasonographic evidence in a male fetusG Pomili, G Venti Donti, L Alunni Carrozza, et al.
Genomics|February 1, 1990
cDNA isolation, expression analysis, and chromosomal localization of two human zinc finger genesL Lania, E Donti, A Pannuti, et al.
European Journal of Haematology|September 1, 1995
Interferon-alpha plus low-dose cytosine arabinoside in advanced phase chronic myelogenous leukaemia patientsA Ferrajoli, A M Liberati, P Caricchi, et al.
Genetic Counseling (Geneva, Switzerland)|April 28, 2010
Familial pericentric inversion of chromosome 18: intrafamilial variability of the recombinant dup(18q)P Prontera, B Buldrini, V Aiello, et al.
European Journal of Pediatrics|April 1, 1983
Clinical heterogeneity in Sanfilippo disease (mucopolysaccharidosis III) type D: presentation of two new casesG V Coppa, P L Giorgi, L Felici, et al.
European Journal of Haematology|March 1, 1994
Repeated PCR in CML during IFN-alpha therapyA M Liberati, E Donti, C Rosso, et al.
Oncogene|October 1, 1990
Mapping of chromosome 17 breakpoints in acute myeloid leukemiasL Longo, E Donti, A Mencarelli, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Evolving modalities of treatment with interferon alfa-2b for Ph1-positive chronic myelogenous leukaemiaE Morra, G Alimena, M Lazzarino, et al.
Cancer Genetics and Cytogenetics|October 1, 1996
Complex chromosome translocations of standard t(8;21) and t(15;17) arise from a two-step mechanism as evidenced by fluorescence in situ hybridization analysisG Calabrese, T Min, L Stuppia, et al.
Blood|August 1, 1988
Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administrationG Alimena, E Morra, M Lazzarino, et al.
Pageof 7